← All trials
NCT02072954
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 1, 2013
- Primary completion
- Feb 1, 2014
- Completion date
- Jun 1, 2014
- First posted
- —
- Last posted
- —
- Enrollment
- 48
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Amneal PharmaceuticalsLead sponsor
- Accutest Research Laboratories (I) Pvt. Ltd.Overall official - principal investigator
- Accutest Research Laboratories (I) Pvt. Ltd.Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.